These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 452871

  • 1. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol.
    Jaschevatzky OE, Anderman S, Shalit A, Kampf D, Grünstein S.
    Acta Obstet Gynecol Scand; 1979; 58(2):175-8. PubMed ID: 452871
    [Abstract] [Full Text] [Related]

  • 2. Effect of quinestrol on plasma and urinary gonadotropins of postmenopausal women.
    Ricciardi I, Bruni G, Imparato E, Marino L, Pesando P.
    Horm Metab Res; 1975 Jul; 7(4):323-6. PubMed ID: 1150131
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
    Sipinen S, Lähteenmäki P, Luukkainen T.
    Acta Obstet Gynecol Scand; 1980 Jul; 59(2):149-53. PubMed ID: 6773291
    [Abstract] [Full Text] [Related]

  • 4. Pill-a-month as an oral contraceptive.
    Hefnawi F, Hassanein M, Younis N.
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [Abstract] [Full Text] [Related]

  • 5. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C, Vekemans M.
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [Abstract] [Full Text] [Related]

  • 6. Replacement estrogen therapy for menopausal vasomotor flushes. Comparison of quinestrol and conjugated estrogens.
    Baumgardner SB, Condrea H, Daane TA, Dorsey JH, Jurow HN, Shively JP, Wachsman M, Wharton LR, Zibel MJ.
    Obstet Gynecol; 1978 Apr; 51(4):445-52. PubMed ID: 208034
    [Abstract] [Full Text] [Related]

  • 7. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M, Carlström K.
    Acta Obstet Gynecol Scand; 1977 Apr; 56(4):351-61. PubMed ID: 602703
    [Abstract] [Full Text] [Related]

  • 8. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U, Mashchak CA, Mishell DR.
    Am J Obstet Gynecol; 1985 Apr 01; 151(7):868-77. PubMed ID: 3920910
    [Abstract] [Full Text] [Related]

  • 9. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul 01; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 10. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels.
    Schiff I, Tulchinsky D, Ryan KJ, Kadner S, Levitz M.
    Am J Obstet Gynecol; 1980 Dec 15; 138(8):1137-41. PubMed ID: 6778214
    [Abstract] [Full Text] [Related]

  • 11. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K.
    Menopause; 2008 Dec 15; 15(1):51-8. PubMed ID: 18257142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Changes in carbohydrate tolerance in the puerperium by inhibition of lactation with bromocriptine and quinestrol (author's transl)].
    Peters FD, Roemer VM.
    Arch Gynakol; 1977 Sep 30; 223(2):93-7. PubMed ID: 578680
    [Abstract] [Full Text] [Related]

  • 14. Contraceptive effect and tolerance of monthly oral doses of quinestrol (author's transl).
    Jaschevatzky OE, Shalit A, Grunstein S.
    Acta Eur Fertil; 1972 Sep 30; 3(3):269-80. PubMed ID: 4679562
    [Abstract] [Full Text] [Related]

  • 15. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Sep 30; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 16. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 15; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 19. Fertility following termination of the once-a-month oral contraceptive.
    Maqueo-Topete M, Mischler TW.
    Contraception; 1974 Sep 15; 10(3):299-304. PubMed ID: 4442272
    [Abstract] [Full Text] [Related]

  • 20. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S, Collins WP, Thom MH, Studd JW.
    Br Med J; 1979 Apr 14; 1(6169):983-5. PubMed ID: 219937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.